EM2408E "Beyond Checkpoints: Evolving Management of Advanced Melanoma" (IM GR - 082324)

Purpose and Overview

The purpose of this presentation is to give an overview of the therapeutic landscape for advanced melanoma.  We will review and focus on the current management with immune checkpoint inhibitors including adjuvant therapy and treatment for metastatic disease.  We will discuss novel and emerging therapies beyond immune checkpoint inhibitors including relevant studies.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Identify the mechanism of action for immune checkpoint inhibitors and other therapies in advanced melanoma
  • Understand the best practices for immune checkpoint inhibitors in treating advanced melanoma
  • Describe novel and emerging treatments in advanced melanoma
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
08/27/2024
Course expires: 
09/27/2024
Cost:
$0.00
Rating: 
0

Photo: First Last, M.D.Daniel Wang M.D.
Assistant Professor of Internal Medicine
Division of Hematology and Oncology

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome